Dec1 Untitled REF GUIDE FINAL[2]
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Psychosocial Aspects of HIV/AIDS: Children and Adolescents Kristin L
Chapter Title Psychosocial Aspects of HIV/AIDS: Children and Adolescents Kristin L. Close, LMSW Objectives Overview 1. Identify psychosocial factors that affect children and Children and adolescents are an ever-growing part of the adolescents infected with human immunodeficiency human immunodeficiency virus (HIV)/AIDS pandemic. virus (HIV)/AIDS and how these factors relate to In 2007, an estimated 2.1 million children younger than general chronic illness. 15 years were living with HIV, and 290,000 children 2. Identify sources of stigma and discrimination died from the disease in 2007 alone. HIV/AIDS takes against children and adolescents and explore how an enormous physical toll on those infected by the stigma affects disclosure of HIV status. virus as well as those who care for them. However, the 3. Examine issues of death and dying and the grief/ psychological toll of the pandemic is just as significant. bereavement process that follows for survivors. The psychological and social effects of HIV/AIDS are 4. Identify particularly vulnerable pediatric and magnified in today’s youth. adolescent populations and explore reasons why they are at increased risk of HIV/AIDS infection and Children involved in the pandemic face a set of psycho- progression. logical and social issues that must be addressed, not 5. Discuss special issues encountered by adolescents overlooked. This chapter will discuss how children and infected with and affected by HIV/AIDS. adolescents are affected by important aspects of the HIV/ AIDS pandemic, including stigma, disclosure, and death, Key Points as well as how health care professionals can support them while dealing with these challenges. -
Hiv/Aids and Its Impact Hiv/Aids
Section 1 HIV/AIDS and its impact Section 2 Legal and policy HIV/AIDS AND ITS IMPACT framework Section 3 Employers need a clear understanding of HIV/AIDS and the impact of the epidemic in order to plan a workplace programme. Developing workplace policies This Section helps you fi nd basic information about inf HIV and inf AIDS, and their implications for society as a whole as well as for Section 4 the world of work. Implementing workplace programmes To view the contents, click on the headings on the left or scroll through the pages. Section 5 Good practice and lessons learnt HIV/AIDS - the facts The Human Immunodefi ciency Virus (HIV) is a virus that weakens the body’s immune system, ultimately causing AIDS. The Acquired Immune Defi ciency Syndrome (AIDS) is a cluster of medical conditions linke to HIV infection. These conditions include diseases known as inf 2 opportunistic infections, as well as certain cancers. To date there is no cure, but the onset of AIDS can be slowed and symptoms relieved with the appropriate use of antiretroviral drugs (ARVs). A person with HIV is not necessarily sick, and can go on working for a number of years after infection. ARVs make it possible for people to continue living full and productive lives. You are in Section 1 The ILO Code of Practice on HIV/AIDS and the world of work (Appendix I) and the accompanying HIV/AIDS and its impact Education and Training Manual contain basic facts about the epidemic and its implications, conditions that contribute to inf HIV and AIDS – the facts vulnerability, and the gender dimension. -
Curbing Unfair Drug Prices: a Primer for States by the Global Health Justice Partnership Is Licensed Under a Creative Commons Attribution 3.0 Unported License
Curbing Unfair Drug Prices ________________________________________________ A Primer for States Global Health Justice Partnership Policy Paper August 2017 Global Health Justice Partnership of the Yale Law School and the Yale School of Public Health National Physicians Alliance Universal Health Care Foundation of Connecticut Lead Authors: Aaron Berman, Yale School of Public Health, 2017 Theodore Lee, Yale Law School, 2018 Adam Pan, Yale Law School, 2019 Zain Rizvi, Yale Law School, 2017 Arielle Thomas, Yale School of Public Health, 2017 Curbing Unfair Drug Prices: A Primer for States by the Global Health Justice Partnership is licensed under a Creative Commons Attribution 3.0 Unported License. It may be freely reproduced, as long as it is correctly attributed. Yale Global Health Justice Partnership Yale Global Health Justice Partnership The Yale Global Health Justice Partnership (GHJP) is a joint initiative between Yale Law School (YLS) and Yale School of Public Health (YSPH) that trains the next generation of scholars and practitioners to tackle the complex interdisciplinary challenges of global health. The GHJP works with international partners at the interface of law and governance, public health, and medicine to theorize, build analytical frameworks, create knowledge, and mobilize research to help drive the social change necessary for improving the health and wellness of people around the world. Learn more at www.yaleghjp.org. The GHJP offers a practicum course each year that engages students in real-world projects with scholars, activists, lawyers, and other practitioners on issues of health justice. Working papers are produced as a part of these projects, with students as lead authors. Final papers reflect input and revisions by GHJP faculty, partners, staff, and other readers. -
Musician and Composer Owen Pallett on Being Thoughtful About Each Decision You Make
To help you grow your creative practice, our website is available as an email. Subscribe The Creative Independent is a vast resource of emotional and practical guidance. We publish Guides, Focuses, Tips, Interviews, and more to help you thrive as a creative person. Explore our website to find wisdom that speaks to you and your practice… September 3, 2020 - As told to Max Mertens, 2681 words. Tags: Music, Film, Inspiration, Process, Identity, Production, Multi-tasking. On being thoughtful about each decision you make Musician and composer Owen Pallett on maintaining a punk ethos in the world of chamber music, their fool-proof lyric writing method, revisiting old work, and negative inspiration. This is your first solo album in six years, but you’ve been busy in that time with different scores and arranging for other musicians. Did these projects take any creative or financial pressure off you when it came to making this record? Sometimes they do and sometimes they don’t really. Film scores are always kind of a bit of a crapshoot. If you score a film and it becomes a bit of a hit, then you do get residuals off it, so it is a good investment if you pick the right films. I notoriously have a bit of a bad nose for a good script. Back in 2008 or 2007, Gus Van Sant was asking me to possibly score Milk prior to studio involvement, and I remember reading the script and thinking it was bullshit. It won an Oscar for Best Original Screenplay, and I was like “Oh wow, I don’t really have a good nose for that kind of stuff.” Most of the production work and arrangement work that I do is a little more labor of love. -
Big Pharma Takes It
A Public Eye Report – March 2021 Big Pharma takes it all How pharmaceutical corporations profiteer from their privileges – even in a global health crisis like COVID-19 1 COVID-19, SHOWCASE OF A PERVERTED BUSINESS MODEL 3 2 BIG PHARMA’S 10 STRATEGIES FOR CASHING IN 7 2.1 – Determine R & D priorities by potential profits alone 9 2.2 – Abuse patents to lock up knowledge, inflate prices and limit supply 10 2.3 – Direct the system towards the needs of high-income countries 13 2.4 – Avoid public accountability 16 2.5 – Design clinical trials for self-interest 18 2.6 – Socialise risks, privatise profits 20 2.7 – Embrace public investment, reject public returns 22 2.8 – Impose unjustifiable, unchallengeable prices 24 2.9 – Financialise innovation 29 2.10 – Lobby pervasively 31 3 SWITZERLAND IS ‘PHARMALAND’ 33 4 CONCLUSION: WHAT COVID-19 SHOWS US 37 5 TIME TO ACT: OUR DEMANDS 39 Endnotes 42 IMPRINT Big Pharma takes it all: How pharmaceutical corporations profiteer from their privileges – even in a global health crisis like COVID-19. A Public Eye Report, March 2021, 52 pages. | Authors Patrick Durisch, Gabriela Hertig | Contributors Christa Luginbühl, Oliver Classen | Edition Mary Louise Rapaud | Publishers Romeo Regenass, Ariane Bahri | Layout Karin Hutter, karinhutter.com | Icons opak.cc | Cover picture © Tang Ming Tung/Getty Images PUBLIC EYE Dienerstrasse 12, Postfach, CH-8021 Zurich | +41 (0)44 2 777 999 | [email protected] Avenue Charles-Dickens 4, CH-1006 Lausanne | +41 (0)21 620 03 03 | [email protected] Donations IBAN CH64 0900 0000 1001 0813 5, Public Eye | publiceye.ch 1 ��-19, showcase of a perverted business model Monty Rakusen/Keystone © 4 BIG PHARMA TAKES IT ALL “No one is safe until everybody is safe”, “leave no one behind” are mantras that have been oft repeated by state leaders and the World Health Organization (WHO) since the coronavirus pandemic turned our world upside down in spring, 2020. -
WORLD AIDS DAY 2018 the 30Th Anniversary
WORLD AIDS DAY The 30th 2018 Anniversary events • information • stories #BrizWAD2018 | #myredribbon Support people living with HIV this World AIDS Day, make a donation to Brigstowe, local HIV services. Text BRIG05 and your amount to 70072. Thank you. 01 World AIDS Day was founded 30 years ago by two people who were working for the World Health Organisation. The premise was simple: to raise awareness and to dispel stigma. By 1988, tens of thousands of people had died from AIDS-related illness and that number was still rising. There was no promising treatment and people living with HIV and AIDS were experiencing discrimination from employers, landlords and health care professionals. Activist movements had started to rise out of frustration at political apathy in the face of one of the largest public health crisis in modern history. Groups like ACT UP and Treatment Action Group (TAG) were starting to demand the government pay attention. Support and advice organisations were forming to support people living with HIV and AIDS, with the myriad issues that went along with having the virus: housing; work; relationships; and of course, healthcare. Now, 30 years on, where are we? How far have we come? This magazine and programme of events has been designed with our friends, partners, colleagues and of course – people living with HIV – in order to celebrate life, remember those we’ve lost and to raise awareness of an illness that still carries a burden of misunderstanding and stigma. We hope you enjoy reading! Team Brigstowe x 02 Contents The Red Ribbon Project Page 03 #MyRedRibbon Page 04 Rockin the Ribbon since 1987 Page 05 Andy’s Story Page 06 #zerotransmission – THT Page 10 Programme of Events Page 11-17 The Diversity Trust Page 12 UWE Bristol Page 14 Don’t Tell Your Mother Page 17 About Brigstowe Page 18 Support Our Work Page 19 Emily’s Story Page 20 Programme Supporters Page 21 Top HIV Facts Page 22 03 The Red Ribbon Project The Red Ribbon has been an international symbol of HIV and AIDS for years. -
The Structural Power of Strong Pharmaceutical Patent Protection in U.S. Foreign Policy
Loyola University Chicago, School of Law LAW eCommons Faculty Publications & Other Works 2003 The trS uctural Power of Strong Pharmaceutical Patent Protection in U.S. Foreign Policy James T. Gathii Loyola University Chicago, School of Law, [email protected] Follow this and additional works at: http://lawecommons.luc.edu/facpubs Part of the Intellectual Property Law Commons, and the International Law Commons Recommended Citation James T. Gathii, The trS uctural Power of Strong Pharmaceutical Patent Protection in U.S. Foreign Policy, 7 J. Gender Race & Just. 267 (2003). This Article is brought to you for free and open access by LAW eCommons. It has been accepted for inclusion in Faculty Publications & Other Works by an authorized administrator of LAW eCommons. For more information, please contact [email protected]. The Structural Power of Strong Pharmaceutical Patent Protection in U.S. Foreign Policy James Thuo Gathii* While the Chief Justice's dissent says there are 'weapons [such as cartels or boycotts] in the arsenalsofforeign nations' sufficient to enable them to counter anticompetitive conduct ... such ... political remed[ies are] hardly available to a foreign nation faced with the monopolistic control of the supply of medicines needed for the health and safety of its people. I I. INTRODUCTION There are two distinct, albeit mutually reinforcing, stances within U.S. foreign policy on HIV/AIDS. The first of these stances favors strong international pharmaceutical patent protection, unencumbered by any restrictions, as the best alternative to ensuring availability of drugs to treat those infected with HIV/AIDS. 2 Unlike the first stance that is Assistant Professor, Albany Law School. -
FILTER 46: Bone Poem: a Short Story by Cass Mccombs and Albert Herter Illustrations by Albert Herter Carmine Itched His Temple I
FILTER 46: Bone Poem: A Short Story By Cass McCombs and Albert Herter By Cass McCombs and Albert Herter on December 5, 2011 Illustrations by Albert Herter Carmine itched his temple in the direction of the anxiety-producing event, a man in spandex stretching his crotch in a beam of sunlight. A dog howled, the honk of a horn. He who tamed the insects. Carmine was waiting for the main capital woman, who said she’d be wearing pearl glasses on a chain. He crossed his legs to produce a pain in his hip, which usually grounded him for 10 minutes. The trees were a mixture of margarita, neon lime and paradise green. Bullies on bicycles, dolls pushing strollers of dolls pushing strollers of...suddenly, the puncture of high heels. Scenery bushes rattling fever again. She was his scenery, no, programmer. Feeding him new formulas, after the expiration date, sucked dry. Algorithms get juiced, around the block, worn out, like book hookers. She sat on the bench next to him, an envelope tickling his eye. She made her fingers dance up his arm like a spider, which, upon reaching his shoulder, slowly rested one black-tipped foot on his antitragus. He unfolded his legs. She lowered her glasses to reveal two cold black caves emanating vapors. Ten minutes later, Carmine and the main capital woman were driving downtown in his pickup truck to score. She was a friend of a friend, Carmine assumed she’d take a cut in one way or another, a cut from a source Carmine assumed was already cut with lactose or spillover from a fictional price tag, or both. -
Pharmaceutical Direct-To-Consumer Advertising: Analyses of Policy Stakeholders and Supreme Court of Canada Interveners
Western University Scholarship@Western Electronic Thesis and Dissertation Repository 6-22-2017 12:00 AM Pharmaceutical Direct-to-Consumer Advertising: Analyses of Policy Stakeholders and Supreme Court of Canada Interveners Tom T. Eldik The University of Western Ontario Supervisor Dr. Sandra Regan The University of Western Ontario Joint Supervisor Dr. Margaret Ann Wilkinson The University of Western Ontario Graduate Program in Health Information Science A thesis submitted in partial fulfillment of the equirr ements for the degree in Master of Health Information Science © Tom T. Eldik 2017 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Pharmacy Administration, Policy and Regulation Commons Recommended Citation Eldik, Tom T., "Pharmaceutical Direct-to-Consumer Advertising: Analyses of Policy Stakeholders and Supreme Court of Canada Interveners" (2017). Electronic Thesis and Dissertation Repository. 4633. https://ir.lib.uwo.ca/etd/4633 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. Abstract Background: Pharmaceutical direct-to-consumer advertising (DTCA) is a controversial form of advertising that markets prescription pharmaceuticals to patients and consumers. The positions, power, interests and influence of pharmaceutical DTCA stakeholders shape Canadian DTCA policies; however, no focused analysis of DTCA stakeholders has occurred. Methods: This study involved a two-pronged stakeholder analysis: First was a broad analysis of pharmaceutical DTCA stakeholders using Canadian publicly available documents and websites. The second analyzed interveners on pharmaceutical litigation at the Supreme Court of Canada, and the comparisons to a leading tobacco advertising case, RJR-MacDonald v Canada (A.G) and a pharmaceutical DTCA case CanWest Media Works Inc. -
Nursing Care of Patients with HIV/AIDS Participants Guide
NURSIN G CARE OF Nurses provide life-saving and life-enriching care throughout the world. Often they are the first provider—or even the primary provider—for patients with HIV. While medically focused trainings provide a valuable service to the P ATIENTS WITH ATIENTS doctors in HIV care, nurses need training geared to their competencies and roles. To equip nurses in resource- limited areas with this specialized training, Family Health International has developed Nursing Care of Patients with HIV/AIDS. This curriculum is intended for nurses working in facilities ranging from the primary-level health center to the tertiary-level hospital who work in a variety of roles to provide care to those with HIV. As education levels and experience vary, the curriculum was designed to be comprehensive: it includes 15 modules, a facilitator’s guide, and a participant’s guide. Thus, the length of the course can be tailored to fit individual needs. HI V/ AIDS NURSING CARE OF PATIENTS WITH HIV/AIDS PARTICIPant’s GUIDE PARTICI Family Health International 2101 Wilson Boulevard, Suite 700 Arlington, VA 22201 t 703.647.1908 P f 703.516.9781 ant’s GUIDE www.fhi.org [email protected] ISBN 1-933702-16-8 PN-ADK-152 In July 2011, FHI became FHI 360. FHI 360 is a nonprofit human development organization dedicated to improving lives in lasting ways by advancing integrated, locally driven solutions. Our staff includes experts in health, education, nutrition, environment, economic development, civil society, gender, youth, research and technology – creating a unique mix of capabilities to address today’s interrelated development challenges. -
Medicines in Europe: the Most Important Changes in the New Legislation
83 boulevard Voltaire - (F)75558 PARIS CEDEX 11 - Tél. : 33 1 49 23 72 80 / Fax : 33 1 48 07 87 32 N°1004 LA REVUE Translated from Rev Prescrire July-August 2004; 24 (252): 481. Medicines in Europe: the most important changes in the new legislation As we digest the results of the European elec- But we must not drop our guard: patients, tions and the last-minute agreement on the health professionals,consumers,health insurers European Constitution, the drafting process of and concerned politicians still have to ensure that the new legislative framework on medicines for the “competent authorities” fulfil their new human use reminds us once again that European obligations and make the pharmaceutical citizens’ voices can and must be heard. industry respect the legal framework that For more than two years the pharmaceutical European society has chosen for it. majors and their lobbyists took it for granted that “Europe” is not some distant land,but is at the they could obtain made-to-measure legislation heart of many of the most important decisions supporting their own narrow financial that shape our society.And Europe is neither ÉDITORIAL Action bears fruit interests, with scant regard for public health inaccessible nor incomprehensible:we just have or for the economic survival of national health to roll up our sleeves and make sure that care systems. special interest groups are not given a free hand. What they failed to realise was that Euro- Finally, Europe is not “too technical”: each new pean citizens from all quarters, including this dossier implies important choices for society. -
Sleeping Volcanoes” Video
February 20, 2019 For Immediate Release Cass McCombs Presents “Sleeping Volcanoes” Video Tip of the Sphere Tour Kicks Off March 4th Cass McCombs’ ninth full-length album, Tip of the Sphere, was released just over a week ago to a range of praise. Following the recently released “Absentee” video, McCombs returns to the album’s first single and the thematic centerpiece of the album, “Sleeping Volcanoes,” with a video where dancers destroy Tahiti Pehrson’s contemporary art piece, “The Rising Body.” It was shot in San Francisco Financial and Tenderloins districts and in the forests of Marin County. As previously described by McCombs, “Sleeping Volcanoes” is about “people passing each other on the sidewalk unaware of the emotional volatility they are brushing past, like a sleeping volcano that could erupt at any moment.” McCombs and band will embark on their international tour on March 4th (all dates are below). Watch “Sleeping Volcanoes” Video Credits: Artwork and set by Tahiti Pehrson Created by: Cass McCombs, Jaclyn Katz, Noe Chavez, Micah Vassau Edited by Matt Sklar Dancers: Andrea Cortes-Juarbe, Rana Halprin, Ryan Reid, Paolo Speirn, Esme Pehrson Assistant Camera: Kaitlyn Pearce Stream/Purchase Tip of the Sphere Praise for Tip of the Sphere: “Tip of the Sphere again rejects easy definitions and expectations, growing and surprising with every listen.” - Pitchfork “‘Tip of the Sphere’ finds McCombs is enigmatic as ever, but his enthralling talent makes it a treat to snuggle in beneath his songs.” -- Associated Press “[Tip of the Sphere] represents familiar footing within the catalogue of one of indie rock’s most enigmatic artists working — the furthest thing from an insult, considering the impressive consistency of his discography.” - Vulture “His most immersing and casually skillful collection of songs to date.” -- Vanity Fair “[On Tip of the Sphere] McCombs reaches fully toward the idea of songwriting as myth-making .